Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

45.36
Delayed Data
As of Aug 29
 +0.06 / +0.13%
Today’s Change
26.02
Today|||52-Week Range
49.66
+1.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues84.1M93.5M111.2M95.4M
 
 
 
 
 
Cost of Goods Sold6.4M6.6M5.3M5.6M
 
 
 
 
 
Depreciation And Amortization3.7M3.7M4.2M4.4M
 
 
 
 
 
 
Operating ExpensesGross Income74.0M83.1M101.6M85.4M
 
 
 
 
 
General Expenses100.5M108.2M122.6M118.8M
 
 
 
 
 
Research And Development70.8M74.6M92.9M85.6M
 
 
 
 
 
Total Operating Expenses110.6M118.6M132.2M128.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.5M-25.1M-21.0M-33.4M
 
 
 
 
 
Other Expenses0.00288.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.4M-24.9M-20.5M-32.7M
 
 
 
 
 
Net Income-26.4M-24.9M-20.5M-32.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS127.7M139.5M139.9M140.3M
 
 
 
 
 
Shares To Calculate EPS Diluted127.7M139.5M139.9M140.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.18-$0.15-$0.23
 
 
 
 
 
EPS Diluted-$0.21-$0.18-$0.15-$0.23